MBCT for Cancer Patients in Follow-Up

Not Applicable

• Conditions: Pain Management
• Interventions: Behavioral: Mindfulness-Based Cognitive Therapy

• Registration Number: NCT03591237
• Lead Sponsor: University of Aarhus

Brief Summary

The objectives of the present study are: 1) to executing the practical implementation in an oncology department of MBCT for patients who have completed their primary treatment and experience significant cancer- and cancer-treatment-related pain, 2) to evaluate effects on pain and well-being, 3) to explore patient satisfaction with the intervention offered, and 4) to explore possible organizational and individual physical, mental and socio-economic barriers for implementation in relation to drop-outs.

Detailed Description

International research shows that untreated or under treated pain among cancer patients after completion of therapy is a common problem with substantial negative impact on the patients' quality of life and mental and physical function.These challenges have increased interest in psychological pain therapy and among the available methods of psychological intervention, mindfulness-based interventions (MBI) are of particular interest. MBI appears to be particularly relevant for pain, as mindfulness focuses, through different meditation exercises, on concentrating attention on here-and-now experiences and supporting new ways of addressing physical sensations and emotional discomfort, characterized by greater acceptance and openness. MBI has been shown effective in treatment of nonmalignant chronic pain. . Patients seen by all four diagnosis teams at the Oncology Department at AUH are screened for pain (0-10 NRS) in connection with their final consultation with the oncologist. Patients with a pain score of ≥ 4 on one or more of the four pain dimensions questions receive a folder describing MBCT and the treatment plan and are encouraged to contact the MBCT team for more information and scheduling of an interview. If the patient, after initial information either by phone or after the first interview decline the offer to participate, but are willing to be contacted for the purpose of gathering more information about their reasons for not participating, we will send them a brief questionnaire concerning their pain and their reasons for choosing to decline the offer, to complete online. They are also asked to give their permission to collect the same information after three months. All data are collected and registered with REDCap, a high data security project administration system administered by Aarhus University's Clinical Trial Unit. The patients will participate in eight weekly two hour group sessions and will be asked to do an additional 45 minutes of daily training at home. The participants will be asked to record their home training to allow assessment of their adherence to the intervention. The program corresponds to the manualized MBCT program, but with adaptations that take into account the special needs of cancer patients, including somewhat shorter sessions, shorter yoga exercises, and the omission of the all-day session. The sessions include psychoeducation and formalized mindfulness exercises with focus on the participants' here-and-now experience of their pain. The aim of the present project is to evaluate the practical implementation of MBCT, with focus on: 1) the observed effects on pain (primary outcome parameter), 2) effects on quality-of-life (QoL) and on other cancer and cancer-treatment-related late effects associated with pain (secondary outcome parameter), 3) possible barriers for continued participation in the program (drop-out), 4) patient experience and satisfaction with the intervention and its organizational/practical implementation, 5) staff's experience of screening procedure and implementation, and 6) collection of data for use in the evaluation of effects, costs, and savings. For use in the evaluation, the patients complete questionnaires prior to the first session (T1), immediately after the last session (T2), and at a six-month follow-up (T3).

Study Timeline

• Study Start: 2018-03-01
• Study First Submitted: 2018-03-26
• Study First Submitted QC: 2018-07-06
• Study First Posted: 2018-07-19
• Status Verified: 2019-05
• Last Update Submitted: 2019-05-24
• Last Update Posted: 2019-05-28
• Primary Completion: 2019-12-30
• Study Completion: 2020-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• >18 yrs. of age
• completed primary cancer treatment
• experiencing moderate to severe pain >4 (11-point NRS)

Read More

Exclusion Criteria

• incomplete chemotherapy or radiation therapy
• serious psychiatric diagnoses eg. psychosis

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
MBCT	Mindfulness-Based Cognitive Therapy	As patients with significant pain are identified and accept the offer of receiving 'Mindfulness-Based Cognitive Therapy' (MBCT) for pain, they will be consecutively included in groups of 12-20 participants. The patients will participate in eight weekly two hour group sessions and will be asked to do an additional 45 minutes of daily training at home.

Primary Outcome Measures

Name	Time	Method
Pain interference assessed by NRS	Change in pain interference from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Pain interference with daily activities during the last week is assessed by a 11-point numeric rating scale (NRS), range 0-10. (0=no interference, 10=maximal interference).
Pain intensity assessed by NRS	Change in pain intensity from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Pain intensity during the last week is assessed by a 11-point numeric rating scale (NRS), range 0-10. (0=no pain, 10= worst pain ever).

Secondary Outcome Measures

Name	Time	Method
Health-related quality of life assessed by the EQ-5D-3L	Change in health-related quality of life from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Health-realted quality of life is assessed by the EQ-5D, which consists of 5 items, measuring five dimensions of health status: mobility, self-case, usual activities, apin/discomfort, anxiety/depression. Each item is rated by marking a statement representing values at three levels 1-3. Higher scores indicate lower levels of quality of life.
Sleep quality assessed by the ISI	Change in sleep quality from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Sleep difficulties are assessed by the Insomnia Severity Index (ISI), which consists of 7 items. Each item is rated on a 5-point Likert scale, ranging from 0-4. Higher scores indicate higher severity of insomnia.
Pain burden assessed by NRS	Change in pain burden from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Pain burden is assessed by a 11-point numeric rating scale (NRS), range 0-10 "How burdensome have your pain been during the last week" (0=not burdensome, 10=very burdensome).
Symptoms of depression assessed by the BDI	Change in depression symptoms from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Depressive symptoms are assessed by the Beck Depression Index (BDI), which consists of 21 items. Each item is rated by marking a statement representing values from 0-3. Higher scores indicate higher levels of depression symptoms.
Well-being assessed by the WHO-5	Change in well-being from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Well-being is assessed by the World Health Organization Well-Being Index (WHO-5), which consists of 5 items. Each item is rated on a 6-point Likert scale, ranging from 0-5. Higher scores indicate higher levels of well-being.
Fear of cancer recurrence assessed by the FCRI-SF	Change in fear of cancer recurrence from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Fear of cancer recurrence is assessed with the Fear of Cancer Recurrence Inventory - Short Form (FCRI-SF), which consists of 9 items. Each item is rated on a 5-point Likert scale, ranging from 0-4. Higher scores indicate higher levels of fear of cancer recurrence.
Pain quality assessed by the McGill Pain Questionnaire (SF-MPQ-2)	Change in pain quality from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Pain quality is assessed by the McGill Pain Questionnaire, which consists of 22 items representing different descriptors of pain. Each item is rated based on a 0-10 scale (0=no pain, 10=worst pain ever) during the last week. The questionnaire comprises of four parts, including continuous, intermittent, neuropathic and affective pain.
Cancer-related quality of life assessed by EORTC-QLQ-C30	Change in cancer-related quality of life from baseline (day 0) to post-intervention (up to 30 weeks after baseline)	Cancer-related quality of life is assessed with the European Organisation for Research and Treatment of Cancer's quality of life questionnaire (EORTC-QLQ-C30), which consists of 30 items.

Trial Locations

Locations (2)

Dept of Oncology, Aarhus University Hospital; 🇩🇰 Aarhus, Jylland, Denmark

Aarhus University; 🇩🇰 Aarhus, Jylland, Denmark